Clinical trial

Contrast-Enhanced Stereotactic Biopsy

NCT06062992

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2023-10-13

PhaseN/A

Study timeline

Study start (actual)2023-10-13Date precision: day

Registry last updated2026-02-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Breast Neoplasmsunresolved

Breast Cancer Femaleunresolved

Interventions

Contrast Enhanced Stereotactic BiopsyDIAGNOSTIC_TEST

Sponsors & collaborators

Zuyderland Medisch Centrumlead sponsor

Hologic, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06062992 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.